Best of the Year neurodegenerative disease AI Tool

Verge Genomics is a biotechnology company leveraging an all-in-human, AI-powered platform, CONVERGE®, to discover and develop drugs for complex diseases. By analyzing vast human genomic datasets, it aims to accelerate the creation of effective treatments for conditions like ALS, Parkinson's, and Frontotemporal Dementia, moving from discovery to clinic significantly faster than traditional methods.